Viewing Study NCT04525456


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-31 @ 1:20 PM
Study NCT ID: NCT04525456
Status: COMPLETED
Last Update Posted: 2022-05-27
First Post: 2020-06-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Immune Responses With Reduxium
Sponsor: Ogevity Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 0101.2006.0101.0001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View